Notice ID: 9b5dfcec1c6f47a3aa40e352470462e5Combined Synopsis/Solicitation
Luminex FLEXMAP 3D Instrument with xPONENT 4.3 Software or Equal
Archived on August 3, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM UTC−05:00
- Posted
- July 9, 2024
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Place of performance
- Jefferson, AR, 72079
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- 75F40124Q-120539
- Notice ID
- 9b5dfcec1c6f47a3aa40e352470462e5
Description
Luminex FLEXMAP 3D Instrument with xPONENT 4.3 Software or Equal per the attached Combined Synopsis Solicitation 75F40124Q-120539.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75F40124Q-120539- Combined Synopsis
- Combined SynopsisCurrentJul 9, 2024
Luminex FLEXMAP 3D Instrument with xPONENT 4.3 Software or Equal
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Brand Name or Equal Teledyne Instruments Liquid Syringe Pump - Model 260x Pump Module (P/N: 681240830) - 2 Qty. per attached specifications along with the following items: 1. Continuous flow dual electric valve package (1/8 inch valves) for Syrixus 1000x, 500x and 260x (P/N: 601267015) - 1 Qty. 2. Electric Valve Controller for SyriXus pumps (P/N: 681240854) - 1 Qty. Amendment 0001: The purpose of this amendment is to provide question and answer as attached as of 11/10/2026. All other terms and conditions remain unchanged. | 75% | Solicitation | 11/20/2026 |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Illumina, Inc. Acquisition Description: The purpose of this acquisition is to purchase two Illumina MiSeq i100 series instruments. These instruments will be used by the NIH HLA Laboratory to produce high resolution HLA typing results for the numerous transplant protocols supported by the laboratory. It will replace the current Illumina MiSeq instruments in the lab that were purchased in 2021 and 2022. The vendor will discontinue service on the current model of the MiSeq. New instruments are required to ensure time to validate these replacements before discontinuation of service. The total dollar value for this order is $139,100.52. The MiSeq is an integrated instrument that performs clonal amplification, genomic DNA sequencing, and data analysis with base calling, alignment, variant calling, and reporting in a single run. The MiSeq provides the Lab with the highest HLA typing results possible. The transplant protocols served by the HLA Lab require highest resolution possible to increase the chance of a successful transplant. The HLA Lab currently owns two MiSeq instruments, so the procedures and Quality Control assessments are in place. The order aims to replace the Illumina Miseq – s/n M07700 (property ID is 02223449) and s/n M08636 (property ID is 02268689) that were purchased in 2019 and 2022. Replacement is necessary to ensure proper performance of these instruments prior to discontinuation of service for the current model of the Illumina MiSeq instruments by the vendor. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000836) by 12:00 PM eastern standard time on 11/27/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | 70% | Pre-Solicitation | 11/27/2026 |
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00061. This solicitation is issued as a competitivecombined synopsis/solicitation for commercial products or commercial services (BrandName or Equal in accordance with FAR 52.211-6). The Government intends to award acontract or purchase order resulting from this solicitation using full and open competition.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitationfor Commercial Products or Commercial Services (and FAR Subpart 13.5, as applicable).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeksto award a Firm-Fixed-Price (FFP) Purchase Order/Contract in U.S. Dollars (USD) to theresponsible offeror whose proposal represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. ¿This requirement is unrestricted. | 70% | Combined Synopsis | 11/18/2026 |
The Naval Surface Warfare Center Philadelphia Division intends to procure FM-6 ferrogram maker instrument on a sole source to Trico. The proposed contract action is for supplies for which the Government intends to solicit and award to only one source under the authority of FAR 6.302. any questions should be e-mailed to : Joseph.w.aprile2.civ@us.navy.mil Phone Calls will NOT be accepted. | 67% | Special Notice | 11/09/2026 |
Brand Name or Equal Across International 2R50f Dual-Jacketed Glass Filter Reactor - 110V (2R50f.110) per the attached specifications - 1 Qty. | 66% | Solicitation | 11/25/2026 |
Additional Details
Solicitation Number
75F40124Q-120539
Archive Date
Aug 3, 2024
Office Address
Beltsville, MD, 20705